| Company Name |
Parmax Pharma Ltd |
| Face Value |
10 |
| BSE Code |
540359 |
| Year End |
202503 |
| Full Year |
| Equity (Rs.Cr.) |
3.74 |
| B.V. Rs. |
-14.80 |
| Sales Rs. Cr. |
28.20 |
| NP Rs. Cr. |
-1.02 |
| NP Var% |
82.00 |
| Div% |
0.00 |
| CPS Rs. |
0.00 |
| EPS Rs. |
-2.70 |
| Traded Value(Rs.Lakhs) |
0.89 |
| 52 Week High |
55.00 |
| 52 Week Low |
28.00 |
| Price BSE |
35.00 |
| Price NSE |
0.00 |
| Market Capital(Rs. Cr.) |
13.28 |
| P/C Ratio |
1,357.20 |
| P/E Ratio |
-12.80 |
| Price Vs.BV |
-2.36 |
| Year End |
202509 |
| Sales Rs. Cr. |
2.53 |
| NP Rs. Cr. |
-2.08 |
| NP Var % |
-858.00 |
| Year End |
202509 |
| Sales |
22.68 |
| OPM |
-0.75 |
| NP |
-3.41 |
| NP Var% |
-7.41 |
| EPS |
0.00 |
| PE |
0.00 |
|
|